Works matching IS 20590105 AND DT 2023
Results: 200
Deglycosylation of eukaryotic-expressed flagellin restores adjuvanticity.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00738-3
- By:
- Publication type:
- Article
An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00710-1
- By:
- Publication type:
- Article
Rapid emergence and transmission of virulence-associated mutations in the oral poliovirus vaccine following vaccination campaigns.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00740-9
- By:
- Publication type:
- Article
Author Correction: An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
The road to approved vaccines for respiratory syncytial virus.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00734-7
- By:
- Publication type:
- Article
Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELD<sup>TM</sup> and COVAXIN<sup>®</sup> induced immunity in COVID-19 exposed Indians.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00731-w
- By:
- Publication type:
- Article
Update on the development of Group A Streptococcus vaccines.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00730-x
- By:
- Publication type:
- Article
A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00728-5
- By:
- Publication type:
- Article
Q fever immunology: the quest for a safe and effective vaccine.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00727-6
- By:
- Publication type:
- Article
Ensuring equity with pre-clinical planning for chlamydia vaccines.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00726-7
- By:
- Publication type:
- Article
A next-generation GMMA-based vaccine candidate to fight shigellosis.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00725-8
- By:
- Publication type:
- Article
Identifying a causal link between prolactin signaling pathways and COVID-19 vaccine-induced menstrual changes.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00719-6
- By:
- Publication type:
- Article
The potential global cost-effectiveness of prospective Strep A vaccines and associated implementation efforts.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00718-7
- By:
- Publication type:
- Article
An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00710-1
- By:
- Publication type:
- Article
A systematic safety pipeline for selection of T-cell receptors to enter clinical use.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00713-y
- By:
- Publication type:
- Article
Strategic considerations on developing a CHIKV vaccine and ensuring equitable access for countries in need.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00722-x
- By:
- Publication type:
- Article
Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin<sup>®</sup>).
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00717-8
- By:
- Publication type:
- Article
A potent and durable malaria transmission-blocking vaccine designed from a single-component 60-copy Pfs230D1 nanoparticle.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00709-8
- By:
- Publication type:
- Article
Emerging vaccine strategies against the incessant pneumococcal disease.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00715-w
- By:
- Publication type:
- Article
Screening of immunogenic proteins and evaluation of vaccine candidates against Mycoplasma synoviae.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00721-y
- By:
- Publication type:
- Article
C5aR<sup>+</sup> dendritic cells fine-tune the Peyer's patch microenvironment to induce antigen-specific CD8<sup>+</sup> T cells.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00720-z
- By:
- Publication type:
- Article
Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00724-9
- By:
- Publication type:
- Article
The need for a clinical case definition in test-negative design studies estimating vaccine effectiveness.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00716-9
- By:
- Publication type:
- Article
Optimization of an alum-anchored clinical HIV vaccine candidate.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00711-0
- By:
- Publication type:
- Article
Modified influenza M1<sub>58–66</sub> peptide vaccination induces non-relevant T-cells and may enhance pathology after challenge.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00705-y
- By:
- Publication type:
- Article
Author Correction: mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Protective antibody threshold of RTS,S/AS01 malaria vaccine correlates antigen and adjuvant dose in mouse model.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00714-x
- By:
- Publication type:
- Article
Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00701-2
- By:
- Publication type:
- Article
A Strep A vaccine global demand and return on investment forecast to inform industry research and development prioritization.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00690-2
- By:
- Publication type:
- Article
Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00707-w
- By:
- Publication type:
- Article
A human antibody epitope map of the malaria vaccine antigen Pfs25.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00712-z
- By:
- Publication type:
- Article
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00708-9
- By:
- Publication type:
- Article
The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00706-x
- By:
- Publication type:
- Article
Cationic-nanogel nasal vaccine containing the ectodomain of RSV-small hydrophobic protein induces protective immunity in rodents.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00700-3
- By:
- Publication type:
- Article
A TLR7/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine models.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00697-9
- By:
- Publication type:
- Article
Author Correction: Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Author Correction: Modeling the potential health impact of prospective Strep A vaccines.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Maternal and neonatal outcomes of COVID-19 vaccination during pregnancy, a systematic review and meta-analysis.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00698-8
- By:
- Publication type:
- Article
Polymeric epitope-based vaccine induces protective immunity against group A Streptococcus.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00695-x
- By:
- Publication type:
- Article
Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00702-1
- By:
- Publication type:
- Article
Profound structural conservation of chemically cross-linked HIV-1 envelope glycoprotein experimental vaccine antigens.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00696-w
- By:
- Publication type:
- Article
YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00699-7
- By:
- Publication type:
- Article
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00693-z
- By:
- Publication type:
- Article
A lipidated TLR7/8 adjuvant enhances the efficacy of a vaccine against fentanyl in mice.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00694-y
- By:
- Publication type:
- Article
Availability and use of Standards in vaccine development.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00692-0
- By:
- Publication type:
- Article
Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00691-1
- By:
- Publication type:
- Article
A chimeric vaccine protects farmed saltwater crocodiles from West Nile virus-induced skin lesions.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00688-w
- By:
- Publication type:
- Article
Author Correction: Dithranol as novel co-adjuvant for non-invasive dermal vaccination.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
A pilot metabolomic study of drug interaction with the immune response to seasonal influenza vaccination.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00682-2
- By:
- Publication type:
- Article
The rVSV-EBOV vaccine provides limited cross-protection against Sudan virus in guinea pigs.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00685-z
- By:
- Publication type:
- Article